1) Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg. 2003 Jun;75(6 Suppl):S29-35. Review. Cerca con Google

2) Mielniczuk L, Mussivand T, Davies R, Mesana TG, Masters RG, Hendry PJ, Keon WJ, Haddad HA. Patient selection for left ventricular assist devices. Artif Organs. 2004 Feb;28(2):152-7. Review. Cerca con Google

3) Entwistle JW 3rd. Short- and long-term mechanical ventricular assistance towards myocardial recovery. Surg Clin North Am. 2004 Feb;84(1):201-21. Review. Cerca con Google

4) Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007 Jul 31;116(5):497-505. Epub 2007 Jul 16. Cerca con Google

5) Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant. 2006 Jul;25(7):756-64. Review. No abstract available Patient selection for the use of ventricular assist devices as a bridge to transplantation. Ann Thorac Surg. 2003 Jun;75(6 Suppl):S66-71. Review. Cerca con Google

6) Topkara VK, Dang NC, Martens TP, Cheema FH, Liu JF, Liang LM, Cheema AF, Barili F, Oz MC, Naka Y. Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation. J Heart Lung Transplant. 2005 Dec;24(12):2048-53. Epub 2005 Sep 15 Cerca con Google

7) Butler J, Howser R, Portner PM, Pierson RN 3rd. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg. 2005 Jan;79(1):66-73. Cerca con Google

8) Butler J, Howser R, Portner PM, Pierson RN 3rd. Diabetes and outcomes after left ventricular assist device placement. J Card Fail. 2005 Sep;11(7):510-5. Cerca con Google

9) McCampbell B, Wasif N, Rabbitts A, Staiano-Coico L, Yurt RW, Schwartz S. Diabetes and burns: retrospective cohort study. J Burn Care Rehabil. 2002 May-Jun;23(3):157-66. Cerca con Google

10) Gronda E, Bourge RC, Costanzo MR, Deng M, Mancini D, Martinelli L, Torre-Amione G, O'Hara ML, Chambers S. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant. 2006 Sep;25(9):1043-56. Cerca con Google

11) Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001 Nov 15;345(20):1435-43. Cerca con Google

12) Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D; REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation. 2004 Aug 24;110(8):975-81. Epub 2004 Aug 16. Cerca con Google

13)Drews T, Stiller B, HĂĽbler M, Weng Y, Berger F, Hetzer R. Coagulation management in pediatric mechanical circulatory support. ASAIO J. 2007 Sep-Oct;53(5):640-5 Cerca con Google

14)Fries D, Innerhofer P, Streif W, Schobersberger W, Margreiter J, Antretter H, Hörmann C. Coagulation monitoring and management of anticoagulation during cardiac assist device support. Ann Thorac Surg. 2003 Nov;76(5):1593-7. Cerca con Google

15) Meuris B, Arnout J, Vlasselaers D, Schetz M, Meyns B. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants. Cerca con Google

16) Ghez O, Liesner R, Karimova A, Ng C, Goldman A, van Doorn C. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device. ASAIO J. 2006 Nov-Dec;52(6):705-7 Cerca con Google

17)Dang NC, Naka Y. Perioperative pharmacotherapy in patients with left ventricular assist devices. Drugs Aging. 2004;21(15):993-1012. Review Cerca con Google

18) Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas JN. Reverse remodeling during long-term mechanical unloading of the left ventricle. J Mol Cell Cardiol. 2007 Sep;43(3):231-42. Epub 2007 Jun 6. Review. Cerca con Google

19)Milting H, Kassner A, Arusoglu L, Meyer HE, Morshuis M, Brendel R, Klauke B, El Banayosy A, Körfer R. Influence of ACE-inhibition and mechanical unloading on the regulation of extracellular matrix proteins in Cerca con Google

the myocardium of heart transplantation candidates bridged by ventricular assist devices. Eur J Heart Fail. 2006 May;8(3):278-83. Epub 2005 Nov 23. Cerca con Google

20) Morawietz H, Szibor M, Goettsch W, Bartling B, Barton M, Shaw S, Koerfer R, Zerkowski HR, Holtz J. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation. 2000 Nov 7;102(19 Suppl 3):III188-93. Cerca con Google

21) Milting H, Jacob M, Kassner A, Heimann P, Mannherz HG, Becker G, Meyer HE, Böthig D, Arusoglu L, Morshuis M, Körfer R, El Banayosy A. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. J Heart Lung Transplant. 2004 Apr;23(4):396-404. Cerca con Google

22) Klotz S, Naka Y, Oz MC, Burkhoff D. Biventricular assist device-induced right ventricular reverse structural and functional remodeling. J Heart Lung Transplant. 2005 Sep;24(9):1195-201. Cerca con Google

23) Rodrigue-Way A, Burkhoff D, Geesaman BJ, Golden S, Xu J, Pollman MJ, Donoghue M, Jeyaseelan R, Houser S, Breitbart RE, Marks A, Acton S. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant. 2005 Jan;24(1):73-80. Cerca con Google

24) Burkhoff D, Holmes JW, Madigan J, Barbone A, Oz MC. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis. 2000 Jul-Aug;43(1):19-26. Review. Cerca con Google

25) Bruggink AH, van Oosterhout MF, de Jonge N, Ivangh B, van Kuik J, Voorbij RH, Cleutjens JP, Gmelig-Meyling FH, de Weger RA. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant. 2006 Sep;25(9):1091-8. Epub 2006 Aug 2. Cerca con Google

26) Burkhoff D, Klotz S, Mancini DM. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail. 2006 Apr;12(3):227-39. Review. Cerca con Google

27) Jugdutt BI, Butler C. Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support. J Am Coll Cardiol. 2007 Mar 20;49(11):1175-7. Epub 2007 Mar 6. Cerca con Google

28) Latif N, Yacoub MH, George R, Barton PJ, Birks EJ. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant. 2007 Mar;26(3):230-5. Cerca con Google

29) Birks EJ, Hall JL, Barton PJ, Grindle S, Latif N, Hardy JP, Rider JE, Banner NR, Khaghani A, Miller LW, Yacoub MH. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation. 2005 Aug 30;112(9 Suppl):I57-64. Cerca con Google

30) Rodrigue-Way A, Burkhoff D, Geesaman BJ, Golden S, Xu J, Pollman MJ, Donoghue M, Jeyaseelan R, Cerca con Google

Houser S, Breitbart RE, Marks A, Acton S. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant. 2005 Jan;24(1):73-80. Cerca con Google

31) Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006 Nov 2;355(18):1873-84 Cerca con Google

32) Hetzer R, MĂĽller JH, Weng YG, Loebe M, Wallukat G. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2000 Nov;120(5):843-53. Cerca con Google

33) Barton PJ, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation. 2005 Aug 30;112(9 Suppl):I46-50. Cerca con Google

34) MĂĽller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Bieda H, Hummel Cerca con Google

M, Loebe M, Meyer R, Hetzer R. [Temporary mechanical left heart support. Recovery of heart function in patients with end-stage idiopathic dilated cardiomyopathy] Herz. 1997 Oct;22(5):227-36. German. Cerca con Google

35) Hetzer R, MĂĽller J, Weng Y, Wallukat G, Spiegelsberger S, Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg. 1999 Aug;68(2):742-9. Cerca con Google

36) Drews TN, Loebe M, Jurmann MJ, Weng Y, Wendelmuth C, Hetzer R. Outpatients on mechanical circulatory support. Ann Thorac Surg. 2003 Mar;75(3):780-5; Cerca con Google

37)Hoy FB, Clemson BS, Geiss DM, Bond LM, Linett CE, Gomez RC. Intracranial bleed during bridge to transplant may not preclude a successful result. J Heart Lung Transplant. 2001 Aug;20(8):901-3. Cerca con Google

38) Slaughter MS, Tsui SS, El-Banayosy A, Sun BC, Kormos RL, Mueller DK, Massey HT, Icenogle TB, Cerca con Google

Farrar DJ, Hill JD; IVAD Study Group. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg. 2007 Jun;133(6):1573-80. Erratum in: J Thorac Cardiovasc Surg. 2007 Sep;134(3):A34. Cerca con Google

39) Samuels LE, Holmes EC, Hagan K, Gopalan R, Droogan C, Ferdinand F. The Thoratec Implantable Ventricular Assist Device (IVAD): initial clinical experience. Heart Surg Forum. 2006;9(4):E690-2. Cerca con Google

40) Farrar DJ, Reichenbach SH, Rossi SA, Weidman JR. Development of an intracorporeal Thoratec ventricular assist device for univentricular or biventricular support. ASAIO J. 2000 May-Jun;46(3):351-3. Cerca con Google

41) Deng MC, Tjan TD, Asfour B, Gradaus R, Böcker D, Loick HM, Baba HA, Breithardt G, Scheld HH, Borggrefe M, Hammel D. Combining nonpharmacologic therapies for advanced heart failure: the Münster experience with the assist device-defibrillator combination. Am J Cardiol. 1999 Mar 11;83(5B):158D-160D. Cerca con Google

PMID: 10089859 [PubMed - indexed for MEDLINE] Cerca con Google

42) Farrar DJ, Buck KE, Coulter JH, Kupa EJ. Portable pneumatic biventricular driver for the Thoratec ventricular assist device. ASAIO J. 1997 Sep-Oct;43(5):M631-4. Cerca con Google

43) Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano Cerca con Google

RJ Jr, Moazami N. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007 Aug;84(2):515-20 Cerca con Google

44) Tsukui H, Abla A, Teuteberg JJ, McNamara DM, Mathier MA, Cadaret LM, Kormos RL. Cerebrovascular accidents in patients with a ventricular assist device. J Thorac Cardiovasc Surg. 2007 Jul;134(1):114-23. Epub 2007 Jun 4 Cerca con Google

45) Pagani FD, Long JW, Dembitsky WP, Joyce LD, Miller LW. Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Ann Thorac Surg. 2006 Oct;82(4):1413-8. Cerca con Google

46) Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC, Ronan NS, Piccione W Jr, Holman WL, Cerca con Google

Furukawa S, Weinberg AD, Heatley G, Poirier VL, Damme L, Long JW. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg. 2004 Dec;78(6):2123-9; discussion 2129-30. Cerca con Google

47) Gambino A, di Marco F, Feltrin G, Toscano G, Gerosa G, Angelini A, Thiene G. Mechanical and biologic analysis of a 1,512-day-long implanted Novacor left ventricular assist device. J Heart Lung Transplant. 2006 Apr;25(4):492-4. Epub 2006 Feb 8. No abstract available. Cerca con Google

48) Dohmen PM, Laube H, de Jonge K, Konertz W. A reliable test to detect impending pump failure during long-term support on the Novacor N100 Left Ventricular Assist System. Tex Heart Inst J. 2001;28(2):139-41. Cerca con Google

PMID: 11453127 [PubMed - indexed for MEDLINE] Cerca con Google

49) John R, Liao K, Lietz K, Kamdar F, Colvin-Adams M, Boyle A, Miller L, Joyce L. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg. 2007 Aug;134(2):351-8. Cerca con Google

50) De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A. Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant. 2006 Feb;25(2):181-6. Epub 2006 Jan 6. Cerca con Google

51) Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2007 Sep;28(17):2057-63. Epub 2007 Jun 22. Cerca con Google

52) Ottervanger JP, de Feijter P, Gardien M, Serruys PW. [Percutaneous insertion of a left ventricular assist device for cardiogenic shock in a patient with a myocardial infarction] Ned Tijdschr Geneeskd. 2003 Jan 25;147(4):164-6. Dutch. Cerca con Google

53) Gacioch GM, Ellis SG, Lee L, Bates ER, Kirsh M, Walton JA, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol. 1992 Mar 1;19(3):647-53. Cerca con Google

54) Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005 Jul;26(13):1276-83. Epub 2005 Feb 25. Cerca con Google

55) Watterson PA, Woodard JC, Ramsden VS, Reizes JA. VentrAssist hydrodynamically suspended, open, centrifugal blood pump. Artif Organs. 2000 Jun;24(6):475-7. Cerca con Google

56) James NL, Wilkinson CM, Lingard NL, van der Meer AL, Woodard JC. Evaluation of hemolysis in the VentrAssist implantable rotary blood pump. Artif Organs. 2003 Jan;27(1):108-13. Cerca con Google

57) Tansley G, Vidakovic S, Reizes J. Fluid dynamic characteristics Artif Organs. 2000 Jun;24(6):483-7. Cerca con Google

58) Chung MK, Zhang N, Tansley GD, Woodard JC. Impeller behavior and displacement of the VentrAssist implantable rotary blood pump. Artif Organs. 2004 Mar;28(3):287-97. Cerca con Google

59) Ayre PJ, Vidakovic SS, Tansley GD, Watterson PA, Lovell NH. Sensorless flow and head estimation in the VentrAssist rotary blood pump. Artif Organs. 2000 Aug;24(8):585-8. Cerca con Google

60) Yoshino M, Uemura M, Takahashi K, Watanabe N, Hoshi H, Ohuchi K, Nakamura M, Fujita H, Sakamoto T, Takatani S. Design and evaluation of a single-pivot supported centrifugal blood pump. Artif Organs. 2001 Sep;25(9):683-7. Cerca con Google

61) James NL, van der Meer AL, Edwards GA, Snelling SR, Begg JD, Esmore DS, Woodard JC. Implantation of the VentrAssist Implantable Rotary Blood Pump in sheep. ASAIO J. 2003 Jul-Aug;49(4):454-8. Cerca con Google

62) Mitamura Y, Kido K, Yano T, Sakota D, Yambe T, Sekine K, OKamoto E. A hydrodynamically suspended, magnetically sealed mechanically noncontact axial flow blood pump: design of a hydrodynamic bearing. Artif Organs. 2007 Mar;31(3):221-4. Cerca con Google

63) Vidakovic S, Ayre P, Woodard J, Lingard N, Tansley G, Reizes J. Paradoxical effects of viscosity on the VentrAssist rotary blood pump. Artif Organs. 2000 Jun;24(6):478-82. Cerca con Google

64) Fukamachi K. New technologies for mechanical circulatory support: current status and future prospects of CorAide and MagScrew technologies. J Artif Organs. 2004;7(2):45-57. Review. Cerca con Google

65) Doi K, Golding LA, Massiello AL, Kopcak MW Jr, Gerhart RL, Schenk S, Inoue M, Ootaki Y, Fukamachi K. Preclinical readiness testing of the Arrow International CorAide left ventricular assist system. Ann Thorac Surg. 2004 Jun;77(6):2103-10. Cerca con Google

66) Gerhart RL, Horvath DJ, Ochiai Y, Krogulecki AY, Golding LA. The effects of impact on the CorAide ventricular assist device. ASAIO J. 2002 Jul-Aug;48(4):449-52. Cerca con Google

67) Fukamachi K, Ochiai Y, Doi K, Massiello AL, Medvedev AL, Horvath DJ, Gerhart RL, Chen JF, Cerca con Google

Krogulecki AY, Takagaki M, Howard MW, Kopcak MW Jr, Golding LA. Chronic evaluation of the Cleveland Clinic CorAide left ventricular assist system in calves. Artif Organs. 2002 Jun;26(6):529-33. Cerca con Google

68) Ochiai Y, Golding LA, Massiello AL, Medvedev AL, Horvath DJ, Gerhart RL, Chen JF, Krogulecki AY, Takagaki M, Doi K, Howard MW, Fukamachi K. Cleveland clinic CorAide blood pump circulatory support without anticoagulation. ASAIO J. 2002 May-Jun;48(3):249-52. Cerca con Google

69) Ochiai Y, Golding LA, Massiello AL, Medvedev AL, Gerhart RL, Chen JF, Takagaki M, Fukamachi K. In vivo hemodynamic performance of the Cleveland Clinic CorAide blood pump in calves. Ann Thorac Surg. 2001 Sep;72(3):747-52 Cerca con Google

70) Nishinaka T, Schima H, Roethy W, Rajek A, Nojiri C, Wolner E, Wieselthaler GM. The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-totransplant experience. Cerca con Google

Circ J. 2006 Nov;70(11):1421-5 Cerca con Google

71) Komoda T, Weng Y, Nojiri C, Hetzer R. Implantation technique for the DuraHeart left ventricular assist system. J Artif Organs. 2007;10(2):124.Epub 2007 Jun 20. Cerca con Google

72) Nojiri C. [Left ventricular assist system with a magnetically levitated impeller technology] Nippon Geka Gakkai Zasshi. 2002 Sep;103(9):607-10. Review. Japanese. Cerca con Google

73) Pae WE, Connell JM, Boehmer JP, Korfer R, El-Banayosy A, Hetzer R, Vigano M, Pavie A; CUBS Study Group. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant. 2007 Jan;26(1):1- Cerca con Google

74) Lazar RM, Shapiro PA, Jaski BE, Parides MK, Bourge RC, Watson JT, Damme L, Dembitsky W, Hosenpud JD, Gupta L, Tierney A, Kraus T, Naka Y. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004 May 25;109(20):2423-7. Epub 2004 May 3. PMID: 15123534 [PubMed - indexed for MEDLINE] Cerca con Google

75) Thomas CE, Jichici D, Petrucci R, Urrutia VC, Schwartzman RJ. Neurologic complications of the Novacor left ventricular assist device. Ann Thorac Surg. 2001 Oct;72(4):1311-5. PMID: 11603452 [PubMed - indexed for MEDLINE] Cerca con Google

76) Pae WE, Connell JM, Adelowo A, Boehmer JP, Korfer R, El-Banayosy A, Hetzer R, Vigano M, Pavie Cerca con Google

A; Clinical Utility Baseline Study (CUBS) Group. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007 Mar;26(3):219-29 Cerca con Google

77) Holman WL, Park SJ, Long JW, Weinberg A, Gupta L, Tierney AR, Adamson RM, Watson JD, Raines EP, Couper GS, Pagani FD, Burton NA, Miller LW, Naka Y; REMATCH Investigators. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant. 2004 Dec;23(12):1359-65. PMID: 15607664 [PubMed - indexed for MEDLINE] Cerca con Google

78) Copeland JG 3rd, Smith RG, Arabia FA, Nolan PE, Mehta VK, McCarthy MS, Chisholm KA. Comparison of the CardioWest total artificial heart, the novacor left ventricular assist system and the thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg. 2001 Mar;71(3 Suppl):S92-7; discussion S114-5. Cerca con Google

79) Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, McClellan D, Slepian MJ; CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004 Aug 26;351(9):859-67. Cerca con Google

80) Copeland JG, Smith RG, Arabia FA, Nolan PE, Banchy ME. The CardioWest total artificial heart as a bridge to transplantation. Semin Thorac Cardiovasc Surg. 2000 Jul;12(3):238-42. Cerca con Google

81) Copeland JG, Arabia FA, Smith RG, Sethi GK, Nolan PE, Banchy ME. Arizona experience with CardioWest Total Artificial Heart bridge to transplantation. Ann Thorac Surg. 1999 Aug;68(2):756-60. Cerca con Google

82) Copeland JG, Smith RG, Arabia FA, Nolan PE, McClellan D, Tsau PH, Sethi GK, Bose RK, Banchy ME, Covington DL, Slepian MJ. Total artificial heart bridge to transplantation: a 9-year experience with 62 patients. J Heart Lung Transplant. 2004 Jul;23(7):823-31. Cerca con Google

83) Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, McClellan D, Slepian MJ; CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004 Aug 26;351(9):859-67. Cerca con Google

84) Copeland JG 3rd, ArabĂ­a FA, Banchy ME, Sethi GK, Foy B, Long J, Kormos RL, Smith RG. The CardioWest total artificial heart bridge to transplantation: 1993 to 1996 national trial. Ann Thorac Surg. 1998 Nov;66(5):1662-9. Cerca con Google

85) Copeland JG, Smith RG, Arabia FA, Nolan PE, Banchy ME. The CardioWest total artificial heart as a bridge to transplantation. Semin Thorac Cardiovasc Surg. 2000 Jul;12(3):238-42. Cerca con Google

86) Arabia FA, Copeland JG, Smith RG, Sethi GK, Arzouman DA, Pavie A, Duveau D, Keon WJ, Masters R, Foy B, Carrier M, Dembitsky W, Long J, Kormos R. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg. 1997 Apr;11 Suppl:S5-10. Cerca con Google

87)) Frazier OH, Dowling RD, Gray LA Jr, Shah NA, Pool T, Gregoric I. The total artificial heart: where we stand. Cardiology. 2004;101(1-3):117-21 Cerca con Google

88) Nakatani T. [Artificial heart] Kyobu Geka. 2007 May;60(5):365-71. Japanese. Cerca con Google

89) Copeland JG, Arabia FA, Tsau PH, Nolan PE, McClellan D, Smith RG, Slepian MJ. Total artificial hearts: bridge to transplantation. Cardiol Clin. 2003 Feb;21(1):101-13. Review. Cerca con Google

90) Casarotto D, Bottio T, Gambino A, Testolin L, Gerosa G. The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation. J Thorac Cardiovasc Surg. 2003 Feb;125(2):417-8. No abstract available Cerca con Google

91) Bottio T, Gambino A, Casarotto D, Gerosa G, Thiene G. Are valve bioprostheses more prone to structural valve deterioration in mitral than in aortic position? An answer derived from a prolonged experience with the novacor left ventricular assist device. J Heart Lung Transplant. 2004 Apr;23(4):507-9 Cerca con Google

92) Tayara W, Starling RC, Yamani MH, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 2006 May;25(5):504-9. Epub 2006 Mar 30. Cerca con Google

93) Dang NC, Topkara VK, Leacche M, John R, Byrne JG, Naka Y. Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: a two-center study. J Thorac Cardiovasc Surg. 2005 Sep;130(3):693-8 Cerca con Google

94) El-Banayosy A, Cobaugh D, Zittermann A, Kitzner L, Arusoglu L, Morshuis M, Milting H, Tenderich G, Koerfer R. A multidisciplinary network to save the lives of severe, persistent cardiogenic shock patients. Ann Thorac Surg. 2005 Aug;80(2):543-7. Cerca con Google

95) Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Cerca con Google

Hetzer R. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002 Sep 24;106(12 Suppl 1):I203-6 Cerca con Google

96) Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. Cerca con Google

97) Kirklin JK, Holman WL. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances). Curr Opin Cardiol. 2006 Mar;21(2):120-6 Cerca con Google